BSJ020R

· Boston Scientific Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BSJ020R, covering 2026-04-14 to 2026-04-14. Get the full timeline:

Most recent: Clinical Trial Update: A Prospective, Multi-center Study to Evaluate Efficacy and Safety of BSJ020R in Treatment of AVF for Hemodialysis (RANGER AV Japan Study) [NA]

See pricing